These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 30110533)

  • 1. Structure-Based Design of Novel EphA2 Agonistic Agents with Nanomolar Affinity in Vitro and in Cell.
    Gambini L; Salem AF; Udompholkul P; Tan XF; Baggio C; Shah N; Aronson A; Song J; Pellecchia M
    ACS Chem Biol; 2018 Sep; 13(9):2633-2644. PubMed ID: 30110533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effective Tumor Targeting by EphA2-Agonist-Biotin-Streptavidin Conjugates.
    Udompholkul P; Baggio C; Gambini L; Sun Y; Zhao M; Hoffman RM; Pellecchia M
    Molecules; 2021 Jun; 26(12):. PubMed ID: 34204178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targefrin: A Potent Agent Targeting the Ligand Binding Domain of EphA2.
    Baggio C; Udompholkul P; Gambini L; Pellecchia M
    J Med Chem; 2022 Nov; 65(22):15443-15456. PubMed ID: 36331527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engineering nanomolar peptide ligands that differentially modulate EphA2 receptor signaling.
    Gomez-Soler M; Petersen Gehring M; Lechtenberg BC; Zapata-Mercado E; Hristova K; Pasquale EB
    J Biol Chem; 2019 May; 294(22):8791-8805. PubMed ID: 31015204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction of Circulating Cancer Cells and Metastases in Breast-Cancer Models by a Potent EphA2-Agonistic Peptide-Drug Conjugate.
    Salem AF; Wang S; Billet S; Chen JF; Udompholkul P; Gambini L; Baggio C; Tseng HR; Posadas EM; Bhowmick NA; Pellecchia M
    J Med Chem; 2018 Mar; 61(5):2052-2061. PubMed ID: 29470068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic Targeting of Pancreatic Cancer via EphA2 Dimeric Agonistic Agents.
    Salem AF; Gambini L; Udompholkul P; Baggio C; Pellecchia M
    Pharmaceuticals (Basel); 2020 May; 13(5):. PubMed ID: 32397624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and Characterization of Novel EphA2 Agonists for Targeted Delivery of Chemotherapy to Cancer Cells.
    Wu B; Wang S; De SK; Barile E; Quinn BA; Zharkikh I; Purves A; Stebbins JL; Oshima RG; Fisher PB; Pellecchia M
    Chem Biol; 2015 Jul; 22(7):876-887. PubMed ID: 26165155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and analysis of EphA2-SAM peptide ligands: A multi-disciplinary screening approach.
    Mercurio FA; Di Natale C; Pirone L; Marasco D; Calce E; Vincenzi M; Pedone EM; De Luca S; Leone M
    Bioorg Chem; 2019 Mar; 84():434-443. PubMed ID: 30576907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NMR studies of a heterotypic Sam-Sam domain association: the interaction between the lipid phosphatase Ship2 and the EphA2 receptor.
    Leone M; Cellitti J; Pellecchia M
    Biochemistry; 2008 Dec; 47(48):12721-8. PubMed ID: 18991394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Sam-Sam interaction between Ship2 and the EphA2 receptor: design and analysis of peptide inhibitors.
    Mercurio FA; Di Natale C; Pirone L; Iannitti R; Marasco D; Pedone EM; Palumbo R; Leone M
    Sci Rep; 2017 Dec; 7(1):17474. PubMed ID: 29234063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An ephrin mimetic peptide that selectively targets the EphA2 receptor.
    Koolpe M; Dail M; Pasquale EB
    J Biol Chem; 2002 Dec; 277(49):46974-9. PubMed ID: 12351647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Target hopping as a useful tool for the identification of novel EphA2 protein-protein antagonists.
    Tognolini M; Incerti M; Pala D; Russo S; Castelli R; Hassan-Mohamed I; Giorgio C; Lodola A
    ChemMedChem; 2014 Jan; 9(1):67-72. PubMed ID: 24115725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conformational Clamping by a Membrane Ligand Activates the EphA2 Receptor.
    Westerfield JM; Sahoo AR; Alves DS; Grau B; Cameron A; Maxwell M; Schuster JA; Souza PCT; Mingarro I; Buck M; Barrera FN
    J Mol Biol; 2021 Sep; 433(18):167144. PubMed ID: 34229012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting EphA2-Sam and Its Interactome: Design and Evaluation of Helical Peptides Enriched in Charged Residues.
    Mercurio FA; Marasco D; Di Natale C; Pirone L; Costantini S; Pedone EM; Leone M
    Chembiochem; 2016 Nov; 17(22):2179-2188. PubMed ID: 27763725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis and bioevaluation of an EphA2 receptor-based targeted delivery system.
    Barile E; Wang S; Das SK; Noberini R; Dahl R; Stebbins JL; Pasquale EB; Fisher PB; Pellecchia M
    ChemMedChem; 2014 Jul; 9(7):1403-12. PubMed ID: 24677792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A computational and laboratory approach for the investigation of interactions of peptide conjugated natural terpenes with EpHA2 receptor.
    Goncalves BG; Banerjee IA
    J Mol Model; 2023 Jun; 29(7):204. PubMed ID: 37291458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-activity relationship analysis of peptides targeting the EphA2 receptor.
    Mitra S; Duggineni S; Koolpe M; Zhu X; Huang Z; Pasquale EB
    Biochemistry; 2010 Aug; 49(31):6687-95. PubMed ID: 20677833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An Agonistic Antibody to EPHA2 Exhibits Antitumor Effects on Human Melanoma Cells.
    Sakamoto A; Kato K; Hasegawa T; Ikeda S
    Anticancer Res; 2018 Jun; 38(6):3273-3282. PubMed ID: 29848674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural and functional characterization of an agonistic anti-human EphA2 monoclonal antibody.
    Peng L; Oganesyan V; Damschroder MM; Wu H; Dall'Acqua WF
    J Mol Biol; 2011 Oct; 413(2):390-405. PubMed ID: 21867711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sam domain-based stapled peptides: Structural analysis and interaction studies with the Sam domains from the EphA2 receptor and the lipid phosphatase Ship2.
    Mercurio FA; Pirone L; Di Natale C; Marasco D; Pedone EM; Leone M
    Bioorg Chem; 2018 Oct; 80():602-610. PubMed ID: 30036816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.